Aug. 20, 2013 — In a laboratory, preclinical study recently published by the journal Organic & Biomolecular Chemistry, Virginia Commonwealth University Massey Cancer Center researchers combined structural features from anti-nausea drug thalidomide with common kitchen spice turmeric to create hybrid… Read More ›
American Cancer Society
IRS agent in charge of Cincinnati Exempt Organizations during tax exemptions scandal has been promoted
Cindy Thomas has been promoted to the senior technical team for the Director of Exempt Organizations Thomas was in charge of the Exempt Organizations Office in Cincinnati when political groups were targeted for extra scrutiny Thomas is filling a role… Read More ›
Outdated practice of annual cervical-cancer screenings may cause more harm than good
Tuesday, July 09, 2013 For decades, women between the ages of 21 and 69 were advised to get annual screening exams for cervical cancer. In 2009, however, accumulating scientific evidence led major guideline groups to agree on a new… Read More ›
Naturally-occurring substance proves effective against deadly skin cancer in laboratory tests
Contact: Joseph Carey jcarey@txbiomed.org 210-258-9437 Texas Biomedical Research Institute For the first time, scientists have demonstrated the mechanism of action of gossypin, a naturally-occurring substance found in fruits and vegetables, as a treatment for melanoma, which causes the majority of… Read More ›
Arrhythmia drug may increase cancer risk ( Up to 46% after 2.5 years )
Contact: Amy Molnar sciencenewsroom@wiley.com Wiley One of the most widely used medications to treat arrhythmias may increase the risk of developing cancer, especially in men and people exposed to high amounts of the drug. That is the conclusion of a… Read More ›
Man Says Kaiser Business Model Includes Death
By PHILIP A. JANQUART LOS ANGELES (CN) – Kaiser Foundation Health Plan refuses to pay for care necessary to save a man’s life, he claims in court. Jalal Afshar, 58, suffers from Castleman’s disease, a rare condition known… Read More ›
87th Health Research Report 19 AUG 2010 – Reconstruction
Health Research Report 87th Issue 19 AUG 2010 Compiled By Ralph Turchiano http://www.vit.bz http://www.youtube.com/vhfilm http://www.facebook.com/engineeringevil http://www.engineeringevil.com http://www.healthresearchreport.me Editors Top Five: SCIENTISTS TARGET POSSIBLE CAUSE OF ONE FORM OF BOWEL DISEASE Pancreatic cancers use fructose, common in the Western diet, to… Read More ›
No such thing as ‘junk RNA,’ say Pitt researchers
2009 study posted for filing Contact: Anita Srikameswaran SrikamAV@upmc.edu 412-578-9193 University of Pittsburgh Schools of the Health Sciences PITTSBURGH, Oct. 12 – Tiny strands of RNA previously dismissed as cellular junk are actually very stable molecules that may play significant… Read More ›
Report: Prostate cancer screening has yet to prove its worth
2009 study posted for filing Contact: David Sampson david.sampson@cancer.org American Cancer Society ATLANTA—June 29, 2009—The recent release of two large randomized trials suggests that if there is a benefit of screening, it is, at best, small, says a new report… Read More ›
Ginger causes ovarian cancer cells to die, U-M researchers find
2006 study posted for filing Contact: Nicole Fawcett nfawcett@umich.edu 734-764-2220 University of Michigan Health System Cell studies show promise for ginger as potential ovarian cancer treatment ANN ARBOR, Mich. — Ginger is known to ease nausea and control inflammation. But… Read More ›
New study shows that a cough medicine ingredient could effectively treat prostate cancer: noscapine reduced tumor growth in mice by 60% and limited the spread of tumors by 65%
2008 study posted for filing Contact: Dr. Israel Barken drbarken@pcref.org 619-461-8181 MedInsight Research Institute Baltimore, MD — A study published today in the December issue of the European medical journal Anticancer Research demonstrates that an ingredient used in a common… Read More ›
LOYOLA TESTING MELANOMA TREATMENT THAT BOOSTS PATIENT’S IMMUNE SYSTEM TO FIGHT DEADLY CANCER
Contact: Jim Ritter Media Relations jritter@lumc.edu (708) 216-2445 Anne Dillon Director, Media Relations adillon@lumc.edu (708) 216-8232 More Sharing ServicesShare MAYWOOD, Ill. – Loyola University Medical Center has launched the first clinical trial in the Midwest of an experimental melanoma… Read More ›
Study: Routine ovarian cancer screenings are ineffective
By Agence France-Presse Tuesday, September 11, 2012 14:01 EDT Topics: cancer specialists ♦ ovarian cancer ♦ US Preventive Services Task Force member Routine screening for ovarian cancer is ineffective and at times can do more harm than good, a panel… Read More ›
Breast cancer risks acquired in pregnancy may pass to next 3 generations
Contact: John Pastor jdpastor@vt.edu 540-231-5646 Virginia Tech Chemicals or foods that raise estrogen levels during pregnancy may increase cancer risk in daughters, granddaughters, and even great-granddaughters, according to scientists from Virginia Tech and Georgetown University. Pregnant rats on a diet… Read More ›
Study reveals inaccuracies in studies of cancer treatment; i.e.Prostate Androgen Therapy had a Higher Death rate than Non
Repost for Filing 2008 Contact: David Sampson david.sampson@cancer.org American Cancer Society Certain biases may exist in observational studies that compare outcomes of different cancer therapies, making the results questionable. That is the conclusion of a new study published in the… Read More ›
Anti-cancer ( Avastin ) drug damages brain vessels
Contact: Hema Bashyam hbashyam@rockefeller.edu 212-327-7053 Journal of Experimental Medicine The cancer drug Avastin (bevacizumab) is used to treat advanced bowel cancer in combination with chemotherapy. This drug targets a protein called VEGF (vascular endothelial growth factor) that stimulates blood vessel… Read More ›
Pitt cancer researchers find key oncoprotein in Merkel cell carcinoma – Cancer Virus
Contact: Anita Srikameswaran SrikamAV@upmc.edu 412-578-9193 University of Pittsburgh Schools of the Health Sciences PITTSBURGH, Aug. 15 – Researchers at the University of Pittsburgh Cancer Institute (UPCI) have identified the oncoprotein that allows a common and usually harmless virus to transform… Read More ›
Avastin, Sutent increase breast cancer stem cells, U-M study shows
ANN ARBOR, Mich. — Cancer treatments designed to block the growth of blood vessels were found to increase the number of cancer stem cells in breast tumors in mice, suggesting a possible explanation for why these drugs don’t lead… Read More ›
HPV improves survival for African-Americans with throat cancer
DETROIT – Even though the human papillomavirus (HPV) is a risk factor for certain head and neck cancers, its presence could make all the difference in terms of survival, especially for African Americans with throat cancer, say Henry Ford Hospital… Read More ›
Review of group-based cancer trials reveals flaws in studies’ design and analysis
COLUMBUS, Ohio – A new study reviewing 75 group-randomized cancer trials over a five-year stretch shows that fewer than half of those studies used appropriate statistical methods to analyze the results. The review suggests that some trials may have reported… Read More ›
Engineering Evil 